As of 2026-04-08, the Relative Valuation of Phathom Pharmaceuticals Inc (PHAT) is (47.52) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.55 USD, the upside of Phathom Pharmaceuticals Inc based on Relative Valuation is -511.4%.
The range of the Relative Valuation is (46.16) - (51.04) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.4x - 19.0x | 17.5x |
| Forward P/E multiples | 14.8x - 18.2x | 16.4x |
| Fair Price | (46.16) - (51.04) | (47.52) |
| Upside | -499.6% - -541.9% | -511.4% |
| Date | P/E |
| 2026-04-07 | -4.11 |
| 2026-04-06 | -4.01 |
| 2026-04-02 | -4.04 |
| 2026-04-01 | -3.97 |
| 2026-03-31 | -3.96 |
| 2026-03-30 | -3.75 |
| 2026-03-27 | -3.77 |
| 2026-03-26 | -3.84 |
| 2026-03-25 | -3.73 |
| 2026-03-24 | -3.58 |
| 2026-03-23 | -3.76 |
| 2026-03-20 | -3.99 |
| 2026-03-19 | -3.97 |
| 2026-03-18 | -3.90 |
| 2026-03-17 | -3.86 |
| 2026-03-16 | -3.72 |
| 2026-03-13 | -3.69 |
| 2026-03-12 | -3.64 |
| 2026-03-11 | -3.97 |
| 2026-03-10 | -3.96 |
| 2026-03-09 | -3.96 |
| 2026-03-06 | -3.80 |
| 2026-03-05 | -3.83 |
| 2026-03-04 | -3.94 |
| 2026-03-03 | -3.94 |
| 2026-03-02 | -4.08 |
| 2026-02-27 | -4.47 |
| 2026-02-26 | -4.83 |
| 2026-02-25 | -4.39 |
| 2026-02-24 | -4.14 |
| 2026-02-23 | -4.05 |
| 2026-02-20 | -4.07 |
| 2026-02-19 | -4.27 |
| 2026-02-18 | -4.23 |
| 2026-02-17 | -4.54 |
| 2026-02-13 | -4.28 |
| 2026-02-12 | -4.28 |
| 2026-02-11 | -4.36 |
| 2026-02-10 | -4.57 |
| 2026-02-09 | -4.55 |
| 2026-02-06 | -4.48 |
| 2026-02-05 | -4.42 |
| 2026-02-04 | -4.71 |
| 2026-02-03 | -4.92 |
| 2026-02-02 | -4.92 |
| 2026-01-30 | -4.87 |
| 2026-01-29 | -4.82 |
| 2026-01-28 | -4.93 |
| 2026-01-27 | -5.07 |
| 2026-01-26 | -5.01 |